2021 FEATURED KEYNOTE PANEL:
POWER OF COLLABORATION: PARTNERING TO SAVE PATIENTS IN A PANDEMIC
Managing Director, SV Health Investors , Chair, UK Vaccine Task Force (Until January 2021)
Kate will speak about her public effort as Chair of the UK Vaccine Taskforce, the group set up by the Government’s Chief Scientific Adviser, Deputy Chief Medical Officer, Business Secretary and Health Secretary to lead UK efforts to find and manufacture a COVID-19 vaccine.
Kate will return to SV Health Investors in early 2021.
Kate won the Lifetime Achievement Award, presented by the BioIndustry Association UK in January 2017.
In her 29 years at SV Health Investors, Kate’s biotech investments have resulted in the launch of six drugs for the treatment of patients with inflammatory and autoimmune disease and cancer.